{"id":"NCT03988634","sponsor":"Novartis Pharmaceuticals","briefTitle":"Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)","officialTitle":"A Multicenter, Randomized, Double-blind, Double Dummy, Parallel Group, Active-controlled Study to Evaluate the Effect of Sacubitril/Valsartan (LCZ696) Versus Valsartan on Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-06-29","primaryCompletion":"2022-12-14","completion":"2022-12-14","firstPosted":"2019-06-17","resultsPosted":"2024-07-29","lastUpdate":"2025-03-06"},"enrollment":467,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure With Preserved Ejection Fraction (HFpEF)"],"interventions":[{"type":"DRUG","name":"sacubitril/valsartan","otherNames":["LCZ696"]},{"type":"DRUG","name":"valsartan","otherNames":[]},{"type":"DRUG","name":"sacubitril/valsartan matching placebo","otherNames":[]},{"type":"DRUG","name":"valsartan matching placebo","otherNames":[]}],"arms":[{"label":"sacubitril/valsartan (LCZ696)","type":"EXPERIMENTAL"},{"label":"valsartan","type":"ACTIVE_COMPARATOR"}],"summary":"The effect of sacubitril/valsartan vs. valsartan on changes in NT-proBNP, safety, and tolerability in HFpEF patients with a WHF event (HFpEF decompensation) who had been stabilized and initiated at the time of or within 30 days post-decompensation.","primaryOutcome":{"measure":"Time-averaged Proportional Change in NT proBNP From Baseline to Weeks 4 and 8","timeFrame":"Baseline, Average of Week 4 and Week 8","effectByArm":[{"arm":"Sacubitril/Valsartan (LCZ696)","deltaMin":0.72,"sd":null},{"arm":"Valsartan","deltaMin":0.8425,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0492"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":97,"countries":["United States","Canada"]},"refs":{"pmids":["40268180","40174692","39505123","38802053","38508844","37212758"],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=1801"]},"adverseEventsSummary":{"seriousAny":{"events":119,"n":233},"commonTop":["SARS-CoV-2 test negative","Hypotension","Hyperkalaemia","Acute kidney injury","Blood creatinine increased"]}}